876617-25-3 Usage
General Description
"(R)-1-BOC-3-FLUORO PYRROLIDINE" is a chemical compound that is composed of a pyrrolidine ring with a fluorine atom and a BOC (tert-butyloxycarbonyl) protecting group attached to the nitrogen atom. It is a chiral compound, with the (R)-enantiomer being the specific form of the compound being referenced. (R)-1-BOC-3-FLUORO PYRROLIDINE has applications in organic synthesis, particularly in the production of pharmaceuticals and other fine chemicals. The BOC protecting group serves to prevent unwanted reactions during synthesis and can be removed under mild conditions to reveal the free amine functionality of the pyrrolidine ring. The fluorine atom can also impart unique chemical properties to the compound, making it useful in various synthetic processes.
Check Digit Verification of cas no
The CAS Registry Mumber 876617-25-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,6,1 and 7 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 876617-25:
(8*8)+(7*7)+(6*6)+(5*6)+(4*1)+(3*7)+(2*2)+(1*5)=213
213 % 10 = 3
So 876617-25-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H16FNO2/c1-9(2,3)13-8(12)11-5-4-7(10)6-11/h7H,4-6H2,1-3H3/t7-/m1/s1
876617-25-3Relevant articles and documents
Halogen-substituted latrotinib compound
-
Paragraph 0119; 0122-0123; 0129-0133, (2021/02/10)
The invention relates to a halogen-substituted latrotinib compound. The halogen-substituted latrotinib compound comprises a latrotinib bisulfate compound labeled by a radioactive halogen atom or a non-radioactive halogen atom. The compound comprises a (R,
2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF
-
Page/Page column 49, (2010/02/08)
The invention relates to pyrrolo pyrimidines of formula (I), wherein Y represents -(CH2)t-O- or -(CH2)r-S-, p is 1 or 2, r is 1, 2 or 3, t is 1, 2 or 3, or Y is -(CH2)j- or -CH=CH-, j is 1 or 2; p is 1 or 2, or Y is -(CH2)f-, f is 1 or 2, p is 1, and the further radicals and symbols have the meaning as defined herein; their preparation, their use as pharmaceuticals, pharmaceutical compositions containing them, the use of such a compound for the manufacture of a pharmaceutical preparation for the treatment of neuropathic pain and to a method for the treatment of such a disease in animals, especially in humans.